Upgrade to SI Premium - Free Trial

Incyte (INCY) Price Target Lifted to $107 at Brean Capital; 'Broad And Robust Pipeline'

April 30, 2015 12:34 PM
Brean Capital analyst Jonathan Aschoff reiterated a Buy rating and boosted his price target on Incyte (NASDAQ: INCY) to $107.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change FDA

Next Articles